| A network of heterogeneous hydrogen bonds in GNRA tetraloops FM Jucker, HA Heus, PF Yip, EHM Moors, A Pardi Journal of molecular biology 264 (5), 968-980, 1996 | 432 | 1996 |
| Towards cleaner production: barriers and strategies in the base metals producing industry EHM Moors, KF Mulder, PJ Vergragt Journal of cleaner production 13 (7), 657-668, 2005 | 222 | 2005 |
| Implementation of artificial intelligence (AI) applications in radiology: hindering and facilitating factors L Strohm, C Hehakaya, ER Ranschaert, WPC Boon, EHM Moors European radiology 30, 5525-5532, 2020 | 204 | 2020 |
| Science, technology and the ‘grand challenge’of ageing—Understanding the socio-material constitution of later life A Peine, A Faulkner, B Jæger, E Moors Technological Forecasting and Social Change 93, 1-9, 2015 | 189 | 2015 |
| Traditional and modern technology assessment: toward a toolkit J Van Den Ende, K Mulder, M Knot, E Moors, P Vergragt Technological Forecasting and Social Change 58 (1-2), 5-21, 1998 | 185 | 1998 |
| Demand articulation in emerging technologies: intermediary user organisations as co-producers? WPC Boon, EHM Moors, S Kuhlmann, REHM Smits Research Policy 40 (2), 242-252, 2011 | 165 | 2011 |
| Clinical comparability and European biosimilar regulations H Schellekens, E Moors Nature biotechnology 28 (1), 28-31, 2010 | 135 | 2010 |
| Reducing post-harvest food losses through innovative collaboration: Insights from the Colombian and Mexican avocado supply chains. C Arias Bustos, EHM Moors Journal of Cleaner Production, 2018 | 129 | 2018 |
| Immunogenicity of mAbs in non-human primates during nonclinical safety assessment PJK Van Meer, M Kooijman, V Brinks, CC Gispen-de Wied, B Silva-Lima, ... MAbs 5 (5), 810-816, 2013 | 129 | 2013 |
| Exploring emerging technologies using metaphors–a study of orphan drugs and pharmacogenomics W Boon, E Moors Social science & medicine 66 (9), 1915-1927, 2008 | 117 | 2008 |
| Institutional power play in innovation systems: The case of Herceptin® P Kukk, EHM Moors, MP Hekkert Research Policy 45 (8), 1558-1569, 2016 | 102 | 2016 |
| Demand articulation in intermediary organisations: The case of orphan drugs in the Netherlands WPC Boon, EHM Moors, S Kuhlmann, REHM Smits Technological forecasting and social change 75 (5), 644-671, 2008 | 98 | 2008 |
| Caring for healthcare entrepreneurs—Towards successful entrepreneurial strategies for sustainable innovations in Dutch healthcare M Janssen, EHM Moors Technological Forecasting and Social Change 80 (7), 1360-1374, 2013 | 97 | 2013 |
| Technology strategies for sustainable metals production systems: a case study of primary aluminium production in The Netherlands and Norway EHM Moors Journal of cleaner production 14 (12-13), 1121-1138, 2006 | 81 | 2006 |
| The dynamics of innovation: a multilevel co-evolutionary perspective E Moors, A Rip, JSC Wiskerke Seeds of transition: essays on novelty production, niches and regimes in …, 2004 | 78 | 2004 |
| Exploring dynamics and strategies of niche protection WPC Boon, EHM Moors, AJ Meijer Research Policy 43 (4), 792-803, 2014 | 76 | 2014 |
| Endogenous regime change: lessons from transition pathways in Dutch dairy farming H Runhaar, L Fünfschilling, A van den Pol-Van Dasselaar, EHM Moors, ... Environmental Innovation and Societal Transitions 36, 137-150, 2020 | 75 | 2020 |
| The creation of legitimacy in grassroots organisations: A study of Dutch community-supported agriculture LM Van Oers, WPC Boon, EHM Moors Environmental Innovation and Societal Transitions 29, 55-67, 2018 | 74 | 2018 |
| Towards a sustainable system of drug development EHM Moors, AF Cohen, H Schellekens Drug discovery today 19 (11), 1711-1720, 2014 | 72 | 2014 |
| The complexities in system building strategies—The case of personalized cancer medicines in England P Kukk, EHM Moors, MP Hekkert Technological Forecasting and Social Change 98, 47-59, 2015 | 65 | 2015 |
